Effective IL-2 therapy

被引：0
|
作者：
DenOtter, W
Everse, LA
Bernsen, MR
Klein, WR
Rutten, VPGM
Stewart, R
Hill, G
Balemans, L
Steerenberg, PA
FiszerMaliszewska, L
Dobrowolski, Z
Zembala, M
机构：
[1] FAC VET MED UTRECHT,NL-3508 TD UTRECHT,NETHERLANDS
[2] FAC VET SCI,HARARE,ZIMBABWE
[3] RIVM,BILTHOVEN,NETHERLANDS
[4] LUDWIK HIRSZFELD INST,WROCLAW,POLAND
[5] FAC MED,KRAKOW,POLAND
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] Reversible lymphocyte anergy during IL-2 therapy
    Fortis, T
    Clementi, E
    IMMUNOLOGY TODAY, 1997, 18 (05): : 254 - 254
  • [22] INTERLEUKIN-2 (IL-2) UPREGULATES IL-2 RECEPTOR EXPRESSION - EVIDENCE THAT IL-2 AUGMENTS IL-2 RECEPTOR MESSENGER-RNA
    DEPPER, J
    LEONARD, W
    DROGULA, C
    KRONKE, M
    WALDMANN, T
    GREENE, W
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 786 - 786
  • [23] Local low-dose IL-2 therapy
    Den Otter, W
    Balemans, L
    Battermann, JJ
    Bernsen, MR
    Cadee, JA
    Dobrowolski, Z
    Everse, LA
    Fiszer-Maliszewska, L
    Gavhumende, R
    De Groot, JW
    De Groot, K
    Hennink, WE
    Hill, FWG
    Jurgenliemp-Schulz, I
    Klein, WR
    Koten, JW
    Maas, RA
    Steerenberg, P
    Stewart, R
    Zembala, M
    HEPATO-GASTROENTEROLOGY, 1999, 46 : 1280 - 1286
  • [24] TARGETING HUMAN IL-2 RECEPTORS FOR DIAGNOSIS AND THERAPY
    NELSON, DL
    KURMAN, CC
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1994, 206 (03): : 309 - 311
  • [25] CLINICAL RELEVANCE OF IL-2 IN TUMOR-THERAPY
    STAHEL, RA
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1989, 131 (08): : 126 - 129
  • [26] Optimal regimes for local IL-2 tumour therapy
    DenOtter, W
    DeGroot, JW
    Bernsen, MR
    Heintz, APM
    Maas, R
    Hordijk, GJ
    Hill, FWG
    Klein, WR
    Ruitenberg, EJ
    Rutten, VPMG
    INTERNATIONAL JOURNAL OF CANCER, 1996, 66 (03) : 400 - 403
  • [27] TUMOR-CELL VACCINATION AND IL-2 THERAPY
    AHLERT, T
    HYBRIDOMA, 1993, 12 (05): : 549 - 552
  • [28] Endogenous IL-33 contributes to Treg expansion induced by IL-2/CD25, a novel IL-2 biologic developed for low-dose IL-2 therapy
    Lui, Jen Bon P.
    Malek, Thomas R.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [29] THE IL-2/IL-2 RECEPTOR SYSTEM - A CURRENT OVERVIEW
    TANIGUCHI, T
    MINAMI, Y
    CELL, 1993, 73 (01) : 5 - 8
  • [30] TOWARDS A STRUCTURE FOR THE IL-2/IL-2 RECEPTOR COMPLEX
    BROCKLEHURST, SM
    MOTT, HR
    CAMPBELL, ID
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 24 - 24
12345